We are live on ! Find out more
PIM

Platinum Investment Management Portfolio holdings

AUM $397M
1-Year Est. Return 63.96%
This Fund
S&P 500
This Quarter Est. Return
+10.86%
1 Year Est. Return
+63.96%
3 Year Est. Return
+135%
5 Year Est. Return
+149.46%
10 Year Est. Return
+636.06%
AUM
$3.61B
AUM Growth
+$212M
Cap. Flow
-$112M
Cap. Flow %
-3.1%
Top 10 Hldgs %
57.31%
Holding
81
New
9
Increased
20
Reduced
22
Closed
7

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$80M
2
BABA icon
Alibaba
BABA
+$53M
3
SINA
Sina Corp
SINA
+$44.8M
4
HBI
Hanesbrands
HBI
+$42.1M
5
QGEN icon
Qiagen
QGEN
+$38.7M

Sector Composition

Rank Sector Weight
1 Communication Services 20.29%
2 Technology 19.04%
3 Consumer Discretionary 16.81%
4 Healthcare 8.58%
5 Energy 7.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ICLR icon
51
Icon
ICLR
$12.4B
$1.87M 0.05%
23,500
NSTG
52
DELISTED
NanoString Technologies, Inc.
NSTG
$1.83M 0.05%
92,000
+17,700
+24% +$337K
INCY icon
53
Incyte
INCY
$24B
$1.8M 0.05%
13,464
-7,000
-34% -$891K
IRWD icon
54
Ironwood Pharmaceuticals
IRWD
$701M
$1.78M 0.05%
124,773
-18,626
-13% -$255K
LIVN icon
55
LivaNova
LIVN
$4.16B
$1.66M 0.05%
33,782
+4,200
+14% +$204K
PFE icon
56
Pfizer
PFE
$149B
$1.63M 0.05%
50,181
GRPN icon
57
Groupon
GRPN
$955M
$1.6M 0.04%
20,350
DERM
58
DELISTED
Dermira, Inc.
DERM
$1.53M 0.04%
44,800
+15,600
+53% +$503K
CFMS
59
DELISTED
Conformis, Inc. Common Stock
CFMS
$1.42M 0.04%
10,850
+3,568
+49% +$604K
BMRN icon
60
BioMarin Pharmaceuticals
BMRN
$11.9B
$1.21M 0.03%
13,820
MRK icon
61
Merck
MRK
$317B
$1.19M 0.03%
19,702
XLRN
62
DELISTED
Acceleron Pharma
XLRN
$1.15M 0.03%
+43,600
New +$1.15M
ACAD icon
63
Acadia Pharmaceuticals
ACAD
$4.9B
$1.11M 0.03%
32,300
-6,000
-16% -$212K
BIIB icon
64
Biogen
BIIB
$30.5B
$1.09M 0.03%
4,000
NXPI icon
65
NXP Semiconductors
NXPI
$58.4B
$983K 0.03%
9,500
RTX icon
66
RTX Corp
RTX
$301B
$897K 0.02%
12,712
TWX
67
DELISTED
Time Warner Inc
TWX
$725K 0.02%
7,421
XLNX
68
DELISTED
Xilinx Inc
XLNX
$648K 0.02%
+11,200
New +$658K
CRUS icon
69
Cirrus Logic
CRUS
$6.23B
$606K 0.02%
10,000
-11,000
-52% -$627K
VRSN icon
70
VeriSign
VRSN
$26.4B
$487K 0.01%
5,600
ATHM icon
71
Autohome
ATHM
$2.62B
$444K 0.01%
14,000
META icon
72
Meta Platforms (Facebook)
META
$1.5T
$275K 0.01%
1,940
AMFW
73
DELISTED
AMEC Foster Wheeler plc
AMFW
$197K 0.01%
29,908
BIVV
74
DELISTED
Bioverativ Inc. Common Stock
BIVV
$108K ﹤0.01%
+2,000
New +$98.5K
MTG icon
75
MGIC Investment
MTG
$6.21B
-274,700
Closed -$2.8M

Similar funds

Platinum Investment Management's Q1 2017 Portfolio in Review

As of Q1 2017, Platinum Investment Management held 81 positions worth $3.61B, up 6.2% from $3.4B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Platinum Investment Management withdrew a net $112M in Q1 2017, closing 7 positions and reducing 22 holdings. Its most notable exit was QIAGEN NV, an estimated $41.2M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 20% of assets, down from 21% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Platinum Investment Management opened a new position in Hanesbrands worth $41.2M.

  • Platinum Investment Management's largest Q1 2017 buy was Hanesbrands: 1,983,800 shares worth $41.2M.
  • Platinum Investment Management added most to Gilead Sciences in Q1 2017, an estimated $80M increase.
  • Platinum Investment Management's biggest Q1 2017 reduction was Level 3 Communications Inc, cutting an estimated $186M.
  • Platinum Investment Management fully exited QIAGEN NV in Q1 2017, selling an estimated $41.2M.
  • Platinum Investment Management's ten largest holdings make up 57% of its $3.61B portfolio in Q1 2017.
  • Platinum Investment Management opened 9 new positions and closed 7 in Q1 2017.
  • Platinum Investment Management's portfolio value rose 6.2% quarter-over-quarter to $3.61B.

Based on Platinum Investment Management's 13F filing for Q1 2017, filed 16 May 2017.